Weijia Cai

8PUBLICATIONS
32CO-AUTHORS
Computational physiologyPredictive and prognostic markersMolecular targetsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 06, 2026
Tissue-specific transfer learning improves functional variant and therapeutic target discoveries in breast and prostate cancer.

|Dec 21, 2022
Stabilized COre gene and Pathway Election uncovers pan-cancer shared pathways and a cancer-specific driver.

Pathum Kossinna, Weijia Cai, Xuewen Lu

|Aug 31, 2022
Raptinal Induces Gasdermin E-Dependent Pyroptosis in Naïve and Therapy-Resistant Melanoma.

Megane Vernon, Nicole A Wilski, Daniel Kotas

|Jun 03, 2022
A Genome-Wide Screen Identifies PDPK1 as a Target to Enhance the Efficacy of MEK1/2 Inhibitors in NRAS Mutant Melanoma.

Weijia Cai, Mai Q Nguyen, Nicole A Wilski

|Mar 17, 2022
Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma.

Claudia Capparelli, Timothy J Purwin, McKenna Glasheen

|May 12, 2020
PBRM1 suppresses tumor growth as a novel p53 acetylation reader.

Weijia Cai, Liya Su, Haifeng Yang

Pageof 2

Frequent Collaborators

4 joint publications

Andrew E Aplin

3 joint publications

Timothy J Purwin

3 joint publications

Nicole Wilski

2 joint publications

Mégane Vernon